HUTCHMED DRC

Company Profile

HUTCHMED DRC had its IPO on 2016-03-17 under the ticker symbol HCM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. HUTCHMED DRC has a staff strength of 1,990 employees.

Stock update

Shares of HUTCHMED DRC opened at $14.7 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $14.63 - $15.04, and closed at $14.88.

This is a -0.47% slip from the previous day's closing price.

A total volume of 127,833 shares were traded at the close of the day’s session.

In the last one week, shares of HUTCHMED DRC have slipped by -3.25%.

HUTCHMED DRC's Key Ratios

HUTCHMED DRC has a market cap of $2.60 billion, indicating a price to book ratio of 3.0277 and a price to sales ratio of 5.9678.

In the last 12-months HUTCHMED DRC’s revenue was $757.24 million with a gross profit of $-271587000 and an EBITDA of $-91185000. The EBITDA ratio measures HUTCHMED DRC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, HUTCHMED DRC’s operating margin was -13.11% while its return on assets stood at -4.98% with a return of equity of -3.4%.

In Q4, HUTCHMED DRC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 163.7%.

HUTCHMED DRC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.27 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into HUTCHMED DRC’s profitability.

HUTCHMED DRC stock is trading at a EV to sales ratio of 4.1435 and a EV to EBITDA ratio of -6.3845. Its price to sales ratio in the trailing 12-months stood at 5.9678.

HUTCHMED DRC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.30 billion

Total Liabilities

$340.86 million

Operating Cash Flow

$0

Capital Expenditure

$9.35 million

Dividend Payout Ratio

0%

HUTCHMED DRC ended 2024 with $1.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.30 billion while shareholder equity stood at $782.04 million.

HUTCHMED DRC ended 2024 with $0 in deferred long-term liabilities, $340.86 million in other current liabilities, 86616000.00 in common stock, $-803057000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $223.00 million and cash and short-term investments were $856.17 million. The company’s total short-term debt was $0 while long-term debt stood at $40.15 million.

HUTCHMED DRC’s total current assets stands at $1.09 billion while long-term investments were $0 and short-term investments were $633.17 million. Its net receivables were $129.20 million compared to accounts payable of $54.58 million and inventory worth $53.88 million.

In 2024, HUTCHMED DRC's operating cash flow was $0 while its capital expenditure stood at $9.35 million.

Comparatively, HUTCHMED DRC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$14.88

52-Week High

$21.28

52-Week Low

$7.39

Analyst Target Price

$46.7473

HUTCHMED DRC stock is currently trading at $14.88 per share. It touched a 52-week high of $21.28 and a 52-week low of $21.28. Analysts tracking the stock have a 12-month average target price of $46.7473.

Its 50-day moving average was $13.92 and 200-day moving average was $14.54 The short ratio stood at 8.62 indicating a short percent outstanding of 0%.

Around 41.3% of the company’s stock are held by insiders while 1490.8% are held by institutions.